MEDIKINE INC
Biotech · Private
Novel peptide mimics of IL-22 for oral delivery to treat inflammatory bowel disease
- Grants
- $485K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 12 granted · 28 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Orally-active peptide agonists of the IL-27 receptor for treatment of inflammatory bowel disease and other autoimmune disorders | $242,263 | |
| Federal grant | Department of Health and Human Services · Phase I · Orally-active peptide agonists of the IL-27 receptor for treatment of inflammatory bowel disease and other autoimmune disorders | $242,263 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1294 | ImmunoTarget Therapeutics, Inc. | — | — |
| 1295 | MEDISYNERGICS, LLC | — | — |
| 1296 | COMPOVAX, LLC | — | — |
| 1297 | MEDIKINE INC | — | — |
| 1298 | NANGIOTX, INC. | — | — |
| 1299 | Seres Therapeutics | — | — |
| 1300 | TOMEGAVAX, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- IL-7RALPHA-GAMMA Ligand Immunoglobulin Fusion Proteinsgranted
- INTERLEUKIN-18 Receptor Binding Polypeptides And Uses Thereofapplication
- IL-7R-ALPHA-GAMMA Binding Compoundsgranted
- Use Of IL-7R-ALPHA-GAMMA Agonist Peptides In Cell Manufacturingapplication
- Use Of IL-2R-BETA-GAMMA Agonist Peptides In Cell Manufacturingapplication
- IL-2R-BETA-GAMMA Binding Compoundsapplication
- IL-7RALPHAGAMMAC Binding Compoundsgranted
- IL-2R-BETA-GAMMA Binding Compoundsgranted
- IL-2ALPHA Receptor Subunit Binding Compoundsgranted
- IL-2RGAMMA Binding Compoundsapplication
- IL-2RGAMMA Binding Compoundsgranted
- IL-2RBETA Binding Compoundsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.